Molecular docking analysis of known flavonoids as duel COX-2 inhibitors in the context of cancer

被引:14
作者
Dash, Raju [1 ]
Uddin, Mir Muhammad Nasir [2 ]
Hosen, S. M. Zahid [3 ]
Bin Rahim, Zahed [1 ]
Dinar, Abu Mansur [4 ]
Kabir, Mohammad Shah Hafez [5 ]
Sultan, Ramiz Ahmed [2 ]
Islam, Ashekul [6 ]
Hossain, Md Kamrul [2 ]
机构
[1] BGC Trust Univ Bangladesh, Dept Pharm, Chittagong 4000, Bangladesh
[2] Univ Chittagong, Dept Pharm, Chittagong 4331, Bangladesh
[3] BCSIR, Pharmacol Res Div, MMDDL, Chittagong 4220, Bangladesh
[4] Sq Pharmaceut Ltd, Qual Control Operat, Dhaka, Bangladesh
[5] Int Islamic Univ Chittagong, Dept Pharm, Chittagong 4203, Bangladesh
[6] Univ Chittagong, Dept Biochem & Mol Biol, Chittagong 4331, Bangladesh
关键词
COX-2; FlexX; ArgusLab; Flavonoids; Cancer;
D O I
10.6026/97320630011543
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cydooxygenase-2 (COX-2) catalyzed synthesis of prostaglandin E2 and it associates with tumor growth, infiltration, and metastasis in preclinical experiments. Known inhibitors against COX-2 exhibit toxicity. Therefore, it is of interest to screen natural compounds like flavanoids against COX-2. Molmular docking using 12 known flavanoids against COX-2 by FlexX and of ArgusLab were performed. All compounds showed a favourable binding energy of >-10 KJ/mol in FlexX and > -8 kcal/mol in ArgusLab. However, this data requires in vitro and in vivo verification for further consideration.
引用
收藏
页码:543 / 549
页数:7
相关论文
共 113 条
[71]   Cancer-related inflammation [J].
Mantovani, Alberto ;
Allavena, Paola ;
Sica, Antonio ;
Balkwill, Frances .
NATURE, 2008, 454 (7203) :436-444
[72]   Luteolin and gefitinib regulation of EGF signaling pathway and cell cycle pathway genes in PC-3 human prostate cancer cells [J].
Markaverich, Barry M. ;
Vijjeswarapu, Mary ;
Shoulars, Kevin ;
Rodriguez, Mary .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2010, 122 (04) :219-231
[73]  
Mason RP, 2006, J CARDIOVASC PHARM, V47, pS7
[74]   Epigenetic targets of bioactive dietary components for cancer prevention and therapy [J].
Meeran, Syed M. ;
Ahmed, Amiya ;
Tollefsbol, Trygve O. .
CLINICAL EPIGENETICS, 2010, 1 :101-116
[75]   Cancer Chemoprevention by Natural Products: How Far Have We Come? [J].
Mehta, Rajendra G. ;
Murillo, Genoveva ;
Naithani, Rajesh ;
Peng, Xinjian .
PHARMACEUTICAL RESEARCH, 2010, 27 (06) :950-961
[76]   Structural approach for COX-2 inhibition [J].
Michaux, C ;
Charlier, C .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2004, 4 (06) :603-615
[77]  
Mutoh H, 2000, JPN J CANCER RES, V91, P686
[78]  
NORTHROP JP, 1993, J BIOL CHEM, V268, P2917
[79]   Open Babel: An open chemical toolbox [J].
O'Boyle, Noel M. ;
Banck, Michael ;
James, Craig A. ;
Morley, Chris ;
Vandermeersch, Tim ;
Hutchison, Geoffrey R. .
JOURNAL OF CHEMINFORMATICS, 2011, 3
[80]   Effect of flavonoids and Vitamin E on cyclooxygenase-2 (COX-2) transcription [J].
O'Leary, KA ;
de Pascual-Tereasa, S ;
Needs, PW ;
Bao, YP ;
O'Brien, NM ;
Williamson, G .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2004, 551 (1-2) :245-254